Chapter 1. Complementary and Alternative Medicine: Definitions and Patterns of Use
1. Pearson NJ, Chesney MA. The CAM Education Program of the National Center for Complementary and Alternative Medicine: an overview. Acad Med. 2007;87:921-6.
2. Brotherton SE, Rockey PH, Etzel SI. US Graduate Medical Education, 2003-2004. JAMA. 2004;292:1032-7.
3. National Center for Complementary and Alternative Medicine: www.nccam.nih.gov/health.
4. Murphy LS, Reinsch S, Najm WI, et al. Searching biomedical databases on complementary medicine: the use of controlled vocabulary among authors, indexers and investigators. BMC Complementary and Alternative Medicine. 2003;3:3.
5. Astin JA. Why patients use alternative medicine: results of a national study. JAMA. 1998;279:1548-53. (Note: The vast majority use CAM in conjunction with conventional care.)
6. nccam.nci.nih.gov/health/whatiscam/index.htm
7. Gundling KE. “When did I become an allopath?” Arch Intern Med. 1998;158:2185-6.
8. www.functionalmedicine.org/
9. vm.cfsan.fda.gov/~dms/dietsupp.html
10. www.cfsan.fda.gov/~dms/dscgmps6.html#fr
12. www.nsf.org
13. Ko RJ. Adulterants in Asian patent medicines. N Engl J Med. 1998;339:847.
14. Mills E, Montori VM, Wu P, et al. Interaction of St. John’s wort with conventional drugs: systematic review of clinical trials. BMJ. 2004;329:27-30.
15.Zhou S, Chan E, Pan SQ, et al. Pharmacokinetic interactions of drugs with St. John’s wort. J Psychopharmacol. 2004;18:262-76.
16. Eisenberg DM, Kessler RC, Van Rompay MI, et al. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med. 2001;135:344-51.
17. Barnes PM, Powell-Griner E (from Division of Health Interview Statistics), and McFann K, Nahin R (from National Center for Complementary and Alternative Medicine, National Institutes of Health). Complementary and Alternative Medicine Use Among Adults: United States, 2002. www.cdc.gov/nchs/data/ad/ad343.pdf Advance Data from Vatl and Health Statistics No. 343. May 27, 2004.
18. Cherkin DC, Deyo RA, Sherman KJ, et al. Characteristics of visits to licensed acupuncturists, chiropractors, massage therapists, and naturopathic physicians. J Am Board Fam Pract. 2002;15:463-72.
19. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. Second Edition. Boston; Little, Brown and Company, 1991.
20. The Cochrane Central Register of Controlled Trials (CENTRAL). The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.
21. Kunz R, Vist G, Oxman AD. Randomisation to protect against selection bias in healthcare trials (Cochrane Methodology Review). In: The Cochrane Library, Issue 3, 2004. Chichester, UK: John Wiley & Sons, Ltd.
22. Kjærgard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med. 2001;135:982-9.
23. Als-Nielsen B, Chen W, Gluud LL, et al. Are trial size and reported methodological quality associated with treatment effects? Observational study of 523 randomised trials. 12 Cochrane Colloquium. Ottawa, Ontario, Canada 2004:102-103.
24. Als-Nielsen B, Gluud LL, Gluud C. Methodological quality and treatment effects in randomised trials: a review of six empirical studies. 12th Cochrane Colloquium. Ottawa, Ontario, Canada 2004:88-89.
25. Chan AW, Hrobjartsson A, Haahr MT, et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004;291:2457-65.
26. Tang J-L, Zhan S-Y, Ernst E. Review of randomized controlled trials of traditional Chinese medicine. BMJ. 1999;319:160-1.
27. Linde K, Jonas WB, Melchart D, Willich S. The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol. 2001;30:526-31.
28. Dickersin K, Rennie D. Registering clinical trials. JAMA. 2003;290:516-23.
29. AW, Krleza-Jeric K, Schmid I, Altman DG. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ. 2004;171:735-40.
30. Vickers A, Goval N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials. 1998;19:159-6.
31. Brien S, Lewith G, Bryant T. Ultramolecular homeopathy has no observable clinical effects. A randomized, double-blind, placebo-controlled proving trial of Belladonna 30C. Br J Clin Pharmozol. 2003;56:562-8.
32. Poitevin B, Davenas E, Benveniste J. In vitro immunological degranulation of human basophils is modulated by lung histamine and Apis mellifica. Br J Clin Pharmacol. 1988;25:439-44.
33. Linde K, Clausius N, Ramirez G, et al. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet. 1997;350:834-43.
34. Linde K, Scholz M, Ramirez G, et al. Impact of study quality on outcome in placebo-controlled trials of homeopathy. J Clin Epidemiol. 1999;52:631-6.
35. Cucherat M, Haugh MC, Gooch M, Boissel JP. Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. HMRAG. Homeopathic Medicine Research Advisory Group. Eur J Clin Pharmacol. 2000;56:27-33.
36. Kleijnen J, Knipschild P, ter Riet G. Clinical trials of homeopathy. BMJ. 1991;302:316-23.
37. Reilly D, Taylor MA, Beattie NG, et al. Is evidence for homeopathy reproducible? Lancet. 1994;344:1601-6.
38. Shang A, Huwiler-Muntener K, Nartey L, et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homeopathy and allopathy. Lancet. 2005;366:726-32.
39. Jonas WB, Anderson RL, Crawford CC, Lyons JS. A systematic review of the quality of homeopathic clinical trials. BMC Complement Altern Med. 2001;1:12. EPub 2001 Dec 31.
40. Jonas WB, Kaptchuk TJ, Linde K. A critical overview of homeopathy. Ann Intern Med. 2003;138:393-9.
| The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. |